Search

everythinglearnresearchcommunity

for

Search:↓

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Entospletinib effectively prevents eye and skin GVHD in mice.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Sgk3 is essential for normal hair follicle growth and maintenance.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

2-DG reduces seizures by enhancing brain inhibition through specific receptor activation.

EGCG may help regrow hair by inhibiting a specific enzyme.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Sgk3 kinase is essential for normal hair growth in mice.

PEVIII is a promising treatment for Pseudomonas aeruginosa keratitis.

JAK inhibitors show promise in treating difficult skin diseases.

Marine compounds from gorgonians and soft corals show promise for drug development, especially for chronic disorders.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

SGK3 is essential for proper hair growth and health.

Removing Gsdma1/2/3 genes reduces skin cell overgrowth by blocking a specific cell pathway.

Quercitrin may help treat Alzheimer's by boosting brain cell signaling without causing tumors.

JAK inhibitors show promise for treating various skin diseases.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

New compounds may help treat heart disease by activating specific potassium channels.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.